益生菌联合康复新液治疗活动期轻中度溃疡性结肠炎患者的临床效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Probiotics combined with Rehabilitation New Fluid in the treatment of patients with active mild to moderate ulcerative colitis.Methods From October 2016 to April 2019, 150 patients with active mild to moderate ulcerative colon admitted to our hospital were selected as the research objects.They were divided into study group and control group by random number table method, 75 cases in each group.The study group was treated with Probiotics combined with Rehabilitation New Fluid, and the control group was treated with Probiotics.After treatment, the total effective rate of treatment, the total score of disease activity, and the total incidence of adverse reactions were compared between the two groups.Results After treatment, the total effective rate of the study group was higher than that of the control group, and the difference was statistically significant (P<0.05).The total activity score of the lesion was lower than that of the control group, and the difference was statistically significant (P<0.05).The total incidence of adverse reactions was not statistically significant between the two groups (P>0.05).Conclusion Probiotics combined Rehabilitation New Fluid is effective in the treatment of patients with active mild to moderate ulcerative colitis, which can effectively reduce the total activity index of patients and promote the rehabilitation of patients, which is worthy of clinical promotion.

Key words： Probiotics Rehabilitation New Fluid Active period Mild to moderate Ulcerative colitis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Zeng-dian

Cite this article:

CHEN Zeng-dian. Clinical effect of Probiotics combined with Rehabilitation New Fluid in the treatment of patients with active mild to moderate ulcerative colitis[J]. 中国当代医药, 2020, 27(12): 64-66.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I12/64

[1]	刘亮，李春涛，牛应林，等.益生菌联合康复新液在活动期轻中度溃疡性结肠炎患者中的临床效果分析[J].中国医刊，2017，52（5）：24-26.
[2]	郭玲.益生菌联合康复新液治疗非重度活动性溃疡性结肠炎的临床效果[J].广西医学，2017，39（10）：1588-1589.
[3]	牛亚敏，冯玉光，张小茜，等.益生菌治疗溃疡性结肠炎有效性及安全性的Meta分析[J].临床药物治疗杂志，2018，16（3）：71-76.
[4]	孔繁玲.益生菌加康复新液治疗活动期轻中度溃疡性结肠炎的效果观察[J].青海医药杂志，2018，48（5）：31-32.
[5]	Alexander CF，Paul M，Steven BH，等.溃疡性结肠炎[J].英国医学杂志：中文版（BMJ），2017，20（20）：392.
[6]	薄茂林，薛芝兰，张涛.3种益生菌制剂联合美沙拉秦口服治疗轻中度溃疡性结肠炎疗效[J].武警医学，2017，28（10）：980-984.
[7]	杜小东，罗利飞.溃疡性结肠炎患者肠道菌群和肠黏膜屏障的变化及益生菌的干预作用[J].中国微生态学杂志，2019，31（2）：75-78.
[8]	王海燕.康复新液联合益生菌治疗活动期轻中度溃疡性结肠炎的疗效[J].实用临床医学，2018，19（9）：23-25.
[9]	冯丽伟，赵岳.益生菌单独用药和联合用药对比安慰剂治疗溃疡性结肠炎的疗效分析[J].世界华人消化杂志，2019，27（6）：26-34.
[10]	彭杏红.益生菌联合美沙拉秦对轻、中度活动期溃疡性结肠炎患者的临床疗效观察[J].临床研究，2019，27（1）：56-57.
[11]	郑明娟，宋红旗，王文娜.复方嗜酸乳杆菌片联合康复新液治疗溃疡性结肠炎30例[J].中国肛肠病杂志，2017，37（10）：20.
[12]	霍锃宏.益生菌联合康复新液治疗活动期轻中度溃疡性结肠炎的可行性观察[J].中国继续医学教育，2017，9（3）：182-184.
[13]	肖铃.益生菌联合康复新液对于活动期轻中度溃疡性结肠炎的治疗效果分析[J].中国处方药，2018，16（2）：66-67.
[14]	陈新俊，钟海兵.自拟凉血止泻方口服合康复新液灌肠治疗活动期溃疡性结肠炎疗效探讨[J].中国中医急症，2017，26（3）：495-497.
[15]	刘艳华.康复新液保留灌肠治疗溃疡性结肠炎的效果观察及护理[J].中国现代药物应用，2019，13（4）：113-114.
[16]	徐青青.康复新液保留灌肠辅助治疗溃疡性结肠炎临床疗效[J].天津药学，2017，29（3）：35-36.